Commission Implementing Decision (EU) 2021/354 of 25 February 2021 postponing the expiry date of approval of propiconazole for use in biocidal products of product-type 8
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
289/2021 In force in the EEA
Yes Legal documents
Commission Implementing Decision (EU) 2021/354 of 25 February 2021 postponing the expiry date of approval of propiconazole for use in biocidal products of product-type 8
Durchführungsbeschluss (EU) 2021/354 der Kommission vom 25. Februar 2021 zur Verschiebung des Ablaufdatums der Genehmigung von Propiconazol zur Verwendung in Biozidprodukten der Produktart 8
Kommisjonens gjennomføringsbeslutning (EU) 2021/354 av 25. februar 2021 om utsettelse av utløpsdatoen for godkjenningen av propikonazol til bruk i biocidprodukter av type 8
History
30.10.2021
Adopted JCD confirmed entry into force date
30.10.2021
Compliance date in the EEA
29.10.2021
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
18.08.2021
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
25.02.2021
Adoption date in the EU
18.03.2021
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.